159 related articles for article (PubMed ID: 12937872)
1. Heavy users of non-steroidal anti-inflammatory drugs: a nationwide prescription database study in Finland.
Helin-Salmivaara A; Klaukka T; Huupponen R
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):477-82. PubMed ID: 12937872
[TBL] [Abstract][Full Text] [Related]
2. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs.
Helin-Salmivaara A; Huupponen R; Virtanen A; Lammela J; Klaukka T
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):425-31. PubMed ID: 15952021
[TBL] [Abstract][Full Text] [Related]
3. Nonaspirin Nonsteroidal Antiinflammatory Drug Use in the Nordic Countries from a Cardiovascular Risk Perspective, 2000-2016: A Drug Utilization Study.
Kristensen KB; Karlstad Ø; Martikainen JE; Pottegård A; Wastesson JW; Zoega H; Schmidt M
Pharmacotherapy; 2019 Feb; 39(2):150-160. PubMed ID: 30636337
[TBL] [Abstract][Full Text] [Related]
4. Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee.
McManus P; Primrose JG; Henry DA; Birkett DJ; Lindner J; Day RO
Med J Aust; 1996 May; 164(10):589-92. PubMed ID: 8637461
[TBL] [Abstract][Full Text] [Related]
5. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
[TBL] [Abstract][Full Text] [Related]
6. The outpatient utilization of non-steroidal anti-inflammatory drugs in South Bačka District, Serbia.
Calasan J; Mijatović V; Horvat O; Varga J; Sabo A; Stilinović N
Int J Clin Pharm; 2011 Apr; 33(2):246-51. PubMed ID: 21744192
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates.
Hallas J; Lauritsen J; Villadsen HD; Gram LF
Scand J Gastroenterol; 1995 May; 30(5):438-44. PubMed ID: 7638569
[TBL] [Abstract][Full Text] [Related]
8. Adoption of celecoxib and rofecoxib: a nationwide database study.
Helin-Salmivaara A; Huupponen R; Virtanen A; Klaukka T
J Clin Pharm Ther; 2005 Apr; 30(2):145-52. PubMed ID: 15811167
[TBL] [Abstract][Full Text] [Related]
9. Associations between prescribing nonsteroidal anti-inflammatory drugs and the potential prescription-related problems in a primary care setting.
Dhabali AA; Awang R; Hamdan Z; Zyoud SH
Int J Clin Pharmacol Ther; 2012 Dec; 50(12):851-61. PubMed ID: 23006441
[TBL] [Abstract][Full Text] [Related]
10. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
11. Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s).
Cox ER; Motheral B; Mager D
Am J Manag Care; 2003 Dec; 9(12):785-94. PubMed ID: 14712755
[TBL] [Abstract][Full Text] [Related]
12. Sex and age differences among tramadol users in three Nordic countries.
Schelde AB; Sørensen AMS; Hindsø M; Christensen MB; Jimenez-Solem E; Eriksson R
Dan Med J; 2020 Jul; 67(7):. PubMed ID: 32734883
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.
Blomqvist P; Feltelius N; Ekbom A; Klareskog L
J Rheumatol; 2000 May; 27(5):1171-7. PubMed ID: 10813283
[TBL] [Abstract][Full Text] [Related]
14. Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers.
Lallana MJ; Feja C; Aguilar-Palacio I; Malo S; Rabanaque MJ
Int J Environ Res Public Health; 2018 Aug; 15(9):. PubMed ID: 30149590
[TBL] [Abstract][Full Text] [Related]
15. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
Khanna R; Smith MJ
Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
[TBL] [Abstract][Full Text] [Related]
16. Cost-efficiency of nonsteroidal anti-inflammatory drug prescribing in Zagreb, Croatia.
Vukusić I; Stimac D; Culig J
Coll Antropol; 2005 Jun; 29(1):143-7. PubMed ID: 16117313
[TBL] [Abstract][Full Text] [Related]
17. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.
Arellano FM; Yood MU; Wentworth CE; Oliveria SA; Rivero E; Verma A; Rothman KJ
Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):861-72. PubMed ID: 17086563
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of gastroprotective agent (GPA) use in adults with arthritis in the United States.
Coyne KS; Margolis MK; Cappelleri JC; Hsieh R; Essex MN; Park PW; Joshi AV
Curr Med Res Opin; 2013 May; 29(5):421-33. PubMed ID: 23444970
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and drug utilization patterns for heavy users of prescription drugs among the elderly: a Danish register-based drug utilization study.
Øymoen A; Pottegård A; Almarsdóttir AB
Eur J Clin Pharmacol; 2015 Jun; 71(6):751-758. PubMed ID: 25912712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
